Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2308 (LINC02308)

Target
LINC02308
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC02308 is a human long intergenic non-coding RNA recognized for its significant overexpression in glioma tissue and association with poor patient prognosis. It functions primarily by binding to specific microRNAs such as miR-30e-3p, thereby modulating their activity and affecting downstream signaling pathways like AKT/mTOR. Through these mechanisms, LINC02308 can promote tumor cell proliferation, inhibit apoptosis, and play an oncogenic role in cancer biology. While not a classical drug target, it receives growing attention as a potential biomarker and mediator in the regulation of gene expression and disease pathways.

02

Mechanism of action

For interacting molecules: Acts by sequestering miR-30e-3p, upregulating TM4SF1, subsequently activating the AKT/mTOR pathway

03

Biological functions

Regulation of gene expression (via miRNA sponging)Promotion of cell proliferationRegulation of apoptosisModulation of oncogenic signaling pathways (AKT/mTOR)
04

Disease associations

Cancer, with specific evidence in glioma
05

Safety considerations

As a non-coding RNA, direct therapeutic targeting presents challenges such as delivery, off-target effects, and RNA stability
06

Biomarkers

Overexpression of LINC02308 may serve as a biomarker for glioma prognosis

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2308 (LINC02308).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2308 (LINC02308).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call